• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白甲基转移酶 MMSET/WHSC1 激活 TWIST1 促进前列腺癌的上皮-间充质转化和侵袭特性。

The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.

机构信息

Division of Hematology/Oncology, Robert H Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.

出版信息

Oncogene. 2013 Jun 6;32(23):2882-90. doi: 10.1038/onc.2012.297. Epub 2012 Jul 16.

DOI:10.1038/onc.2012.297
PMID:22797064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3495247/
Abstract

Epigenetic deregulation of gene expression has a role in the initiation and progression of prostate cancer (PCa). The histone methyltransferase MMSET/WHSC1 (Multiple Myeloma SET domain) is overexpressed in a number of metastatic tumors, but its mechanism of action has not been defined. In this work, we found that PCa cell lines expressed significantly higher levels of MMSET compared with immortalized, non-transformed prostate cells. Knockdown experiments showed that, in metastatic PCa cell lines, dimethylation of lysine 36 and trimethylation of lysine 27 on histone H3 (H3K36me2 and H3K27me3, respectively) depended on MMSET expression, whereas depletion of MMSET in benign prostatic cells did not affect chromatin modifications. Knockdown of MMSET in DU145 and PC-3 tumor cells decreased cell proliferation, colony formation in soft agar and strikingly diminished cell migration and invasion. Conversely, overexpression of MMSET in immortalized, non-transformed RWPE-1 cells promoted cell migration and invasion, accompanied by an epithelial-mesenchymal transition (EMT). Among a panel of EMT-promoting genes analyzed, TWIST1 expression was strongly activated in response to MMSET. Chromatin immunoprecipitation analysis demonstrated that MMSET binds to the TWIST1 locus and leads to an increase in H3K36me2, suggesting a direct role of MMSET in the regulation of this gene. Depletion of TWIST1 in MMSET-overexpressing RWPE-1 cells blocked cell invasion and EMT, indicating that TWIST1 was a critical target of MMSET, responsible for the acquisition of an invasive phenotype. Collectively, these data suggest that MMSET has a role in PCa pathogenesis and progression through epigenetic regulation of metastasis-related genes.

摘要

表观遗传调控基因表达在前列腺癌(PCa)的发生和发展中起作用。组蛋白甲基转移酶 MMSET/WHSC1(多发性骨髓瘤 SET 域)在许多转移性肿瘤中过表达,但作用机制尚未确定。在这项工作中,我们发现 PCa 细胞系表达的 MMSET 水平明显高于永生化的非转化前列腺细胞。敲低实验表明,在转移性 PCa 细胞系中,组蛋白 H3 赖氨酸 36 二甲基化(H3K36me2)和赖氨酸 27 三甲基化(H3K27me3)取决于 MMSET 的表达,而良性前列腺细胞中 MMSET 的耗竭并不影响染色质修饰。在 DU145 和 PC-3 肿瘤细胞中敲低 MMSET 会降低细胞增殖、软琼脂中的集落形成,并且显著减少细胞迁移和侵袭。相反,在永生化的非转化 RWPE-1 细胞中过表达 MMSET 会促进细胞迁移和侵袭,并伴有上皮间质转化(EMT)。在分析的一组促进 EMT 的基因中,TWIST1 的表达受到 MMSET 的强烈激活。染色质免疫沉淀分析表明 MMSET 与 TWIST1 基因座结合,并导致 H3K36me2 增加,表明 MMSET 直接参与该基因的调节。在过表达 MMSET 的 RWPE-1 细胞中敲低 TWIST1 会阻断细胞侵袭和 EMT,表明 TWIST1 是 MMSET 的关键靶点,负责获得侵袭表型。总的来说,这些数据表明 MMSET 通过对转移相关基因的表观遗传调控在 PCa 的发病机制和进展中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/411d233db91b/nihms384653f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/99e911973718/nihms384653f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/2db0165e3890/nihms384653f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/74d3c7392f0c/nihms384653f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/5cb96b6365d6/nihms384653f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/14153d21d2d2/nihms384653f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/8bb5c9b36e43/nihms384653f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/411d233db91b/nihms384653f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/99e911973718/nihms384653f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/2db0165e3890/nihms384653f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/74d3c7392f0c/nihms384653f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/5cb96b6365d6/nihms384653f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/14153d21d2d2/nihms384653f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/8bb5c9b36e43/nihms384653f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b985/3495247/411d233db91b/nihms384653f7.jpg

相似文献

1
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.组蛋白甲基转移酶 MMSET/WHSC1 激活 TWIST1 促进前列腺癌的上皮-间充质转化和侵袭特性。
Oncogene. 2013 Jun 6;32(23):2882-90. doi: 10.1038/onc.2012.297. Epub 2012 Jul 16.
2
Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells.二甲双胍在前列腺癌细胞中发挥抗肿瘤作用并下调组蛋白甲基转移酶多发性骨髓瘤SET结构域(MMSET)。
Prostate. 2016 Dec;76(16):1507-1518. doi: 10.1002/pros.23235. Epub 2016 Jul 12.
3
MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting and in gastric cancer.微小RNA-2392通过靶向胃癌中的[具体基因1]和[具体基因2]抑制转移和上皮-间质转化。
FASEB J. 2017 Sep;31(9):3774-3786. doi: 10.1096/fj.201601140RR. Epub 2017 May 16.
4
MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents.MMSET/WHSC1增强DNA损伤修复,导致对化疗药物的抗性增加。
Oncogene. 2016 Nov 10;35(45):5905-5915. doi: 10.1038/onc.2016.116. Epub 2016 Apr 25.
5
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.组蛋白甲基转移酶MMSET/NSD2通过H3K36和H3K27甲基化的整体和局部变化改变EZH2结合并重新编程骨髓瘤表观基因组。
PLoS Genet. 2014 Sep 4;10(9):e1004566. doi: 10.1371/journal.pgen.1004566. eCollection 2014 Sep.
6
Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.突变型 p53(R175H)上调 Twist1 表达并促进永生化前列腺细胞的上皮间质转化。
Cell Death Differ. 2011 Feb;18(2):271-81. doi: 10.1038/cdd.2010.94. Epub 2010 Aug 6.
7
Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway.肺肿瘤相关树突状细胞衍生的抵抗素通过增加 Wolf-Hirschhorn 综合征候选基因 1/Twist 通路促进肿瘤进展。
Carcinogenesis. 2013 Nov;34(11):2600-9. doi: 10.1093/carcin/bgt281. Epub 2013 Aug 16.
8
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.MMSET 组蛋白甲基转移酶在 t(4;14)多发性骨髓瘤细胞中切换全局组蛋白甲基化并改变基因表达。
Blood. 2011 Jan 6;117(1):211-20. doi: 10.1182/blood-2010-07-298349. Epub 2010 Oct 25.
9
TWIST1-WDR5- Regulates Chromatin to Facilitate Prostate Cancer Metastasis.TWIST1-WDR5调节染色质以促进前列腺癌转移。
Cancer Res. 2017 Jun 15;77(12):3181-3193. doi: 10.1158/0008-5472.CAN-16-2797. Epub 2017 May 8.
10
MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.微小 RNA-106b 通过靶向 TWIST1 调节侵袭性子宫内膜癌细胞系中的上皮-间充质转化。
Mol Carcinog. 2014 May;53(5):349-59. doi: 10.1002/mc.21983. Epub 2013 Sep 3.

引用本文的文献

1
Opposite patterns of association of TWIST1 expression with patient survival in SHH and Group 4 medulloblastoma.在SHH和4组髓母细胞瘤中,TWIST1表达与患者生存率的相反关联模式。
Childs Nerv Syst. 2025 Sep 11;41(1):277. doi: 10.1007/s00381-025-06913-2.
2
Urinary Extracellular Vesicle Signatures as Biomarkers in Prostate Cancer Patients.尿细胞外囊泡特征作为前列腺癌患者的生物标志物
Int J Mol Sci. 2025 Jul 18;26(14):6895. doi: 10.3390/ijms26146895.
3
NASP implication in the androgen receptor associated with castration resistance in prostate cancer.

本文引用的文献

1
Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.组蛋白赖氨酸甲基转移酶 Wolf-Hirschhorn 综合征候选基因 1 通过调节 Wnt 通路参与人类肿瘤发生。
Neoplasia. 2011 Oct;13(10):887-98. doi: 10.1593/neo.11048.
2
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells.一种化学探针可在细胞中选择性抑制 G9a 和 GLP 甲基转移酶的活性。
Nat Chem Biol. 2011 Jul 10;7(8):566-74. doi: 10.1038/nchembio.599.
3
Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.
核仁酸性磷酸蛋白在前列腺癌去势抵抗相关雄激素受体中的作用
Cell Commun Signal. 2025 Jul 10;23(1):331. doi: 10.1186/s12964-025-02339-0.
4
H3K36me2 methyltransferase NSD2/WHSC1 promotes triple-negative breast cancer metastasis via activation of ULK1-dependent autophagy.H3K36me2甲基转移酶NSD2/WHSC1通过激活ULK1依赖性自噬促进三阴性乳腺癌转移。
Autophagy. 2025 Mar 25:1-19. doi: 10.1080/15548627.2025.2479995.
5
Relationship of Signaling Pathways between RKIP Expression and the Inhibition of EMT-Inducing Transcription Factors SNAIL1/2, TWIST1/2 and ZEB1/2.RKIP表达与上皮-间质转化诱导转录因子SNAIL1/2、TWIST1/2和ZEB1/2抑制之间的信号通路关系
Cancers (Basel). 2024 Sep 17;16(18):3180. doi: 10.3390/cancers16183180.
6
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.NSD2 是 AR/FOXA1 新增强子联合体促进前列腺肿瘤发生的必要亚基。
Nat Genet. 2024 Oct;56(10):2132-2143. doi: 10.1038/s41588-024-01893-6. Epub 2024 Sep 9.
7
Multilevel Regulation of NF-κB Signaling by NSD2 Suppresses Kras-Driven Pancreatic Tumorigenesis.NSD2 通过调控 NF-κB 信号通路抑制 Kras 驱动的胰腺肿瘤发生。
Adv Sci (Weinh). 2024 Aug;11(30):e2309387. doi: 10.1002/advs.202309387. Epub 2024 Jun 18.
8
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome.NSD2通过将一碳代谢导向表观基因组,驱动t(4;14)骨髓瘤细胞对腺苷酸激酶2的依赖。
Blood. 2024 Jul 18;144(3):283-295. doi: 10.1182/blood.2023022859.
9
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.NSD2是AR/FOXA1新增强子体促进前列腺肿瘤发生过程中的一个必需亚基。
bioRxiv. 2024 Mar 29:2024.02.22.581560. doi: 10.1101/2024.02.22.581560.
10
NSD family proteins: Rising stars as therapeutic targets.NSD家族蛋白:作为治疗靶点的后起之秀。
Cell Insight. 2024 Feb 3;3(2):100151. doi: 10.1016/j.cellin.2024.100151. eCollection 2024 Apr.
强效小分子 DOT1L 抑制剂选择性杀伤混合谱系白血病细胞。
Cancer Cell. 2011 Jul 12;20(1):53-65. doi: 10.1016/j.ccr.2011.06.009.
4
Epigenetics in prostate cancer: biologic and clinical relevance.前列腺癌中的表观遗传学:生物学和临床相关性。
Eur Urol. 2011 Oct;60(4):753-66. doi: 10.1016/j.eururo.2011.06.035. Epub 2011 Jun 22.
5
Cancers and the NSD family of histone lysine methyltransferases.癌症与组蛋白赖氨酸甲基转移酶的 NSD 家族
Biochim Biophys Acta. 2011 Dec;1816(2):158-63. doi: 10.1016/j.bbcan.2011.05.004. Epub 2011 Jun 6.
6
MMSET is highly expressed and associated with aggressiveness in neuroblastoma.MMSET 在神经母细胞瘤中高度表达,并与侵袭性相关。
Cancer Res. 2011 Jun 15;71(12):4226-35. doi: 10.1158/0008-5472.CAN-10-3810. Epub 2011 Apr 28.
7
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.组蛋白甲基转移酶和潜在的癌蛋白 MMSET 在多种人类肿瘤中过度表达。
Clin Cancer Res. 2011 May 1;17(9):2919-33. doi: 10.1158/1078-0432.CCR-10-1302. Epub 2011 Mar 8.
8
The genomic complexity of primary human prostate cancer.原发性人类前列腺癌的基因组复杂性。
Nature. 2011 Feb 10;470(7333):214-20. doi: 10.1038/nature09744.
9
The epigenome as a therapeutic target in prostate cancer.表观基因组作为前列腺癌的治疗靶点。
Nat Rev Urol. 2010 Dec;7(12):668-80. doi: 10.1038/nrurol.2010.185. Epub 2010 Nov 9.
10
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.MMSET 组蛋白甲基转移酶在 t(4;14)多发性骨髓瘤细胞中切换全局组蛋白甲基化并改变基因表达。
Blood. 2011 Jan 6;117(1):211-20. doi: 10.1182/blood-2010-07-298349. Epub 2010 Oct 25.